Curative Biosciences, Revenue Growth Rates (BEVS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Curative Biosciences, Inc.  (BEVS)
 

BEVS's Revenue Growth by Quarter and Year

Curative Biosciences,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BEVS Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter June -
3rd Quarter March 0.00
2nd Quarter December 0.00
1st Quarter September 0.00
FY 0.00

BEVSs Annual Revenue
Curative Biosciences,'s Revenue in the fiscal year 2017 $ 0.00 millions
Curative Biosciences,'s Revenue in the fiscal year 2016 $ 0.00 millions
Curative Biosciences,'s Revenue in the fiscal year 2015 $ 0.00 millions
Curative Biosciences,'s Revenue in the fiscal year 2014 $ 0.00 millions
Curative Biosciences,'s Revenue in the fiscal year 2012 $ 0.16 millions




BEVS Revenue third quarter 2018 Y/Y Growth Comment
Curative Biosciences, Inc. in the third quarter 2018 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2018, Curative Biosciences, Inc. achieved the best Revenue growth in Nonalcoholic Beverages industry. While Curative Biosciences, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2018.


BEVS Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter June - - - -
3rd Quarter March - - - -
2nd Quarter December - - - -
1st Quarter September - - - -
FY   - - - -

Financial Statements
Curative Biosciences,'s third quarter 2018 Revenue $ 0.00 millions BEVS's Income Statement
Curative Biosciences,'s third quarter 2017 Revenue $ 0.00 millions Quarterly BEVS's Income Statement


BEVS Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter June - - - -
3rd Quarter March - - - -
2nd Quarter December - - - -
1st Quarter September - - - -
FY (Year on Year)   - - - -


Back to BEVS Growth rate Comparisons >> Back to BEVS Growth rate Comparisons >>


Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Curative Biosciences,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEVS's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEVS's III. Quarter Q/Q Revenue Comment


Curative Biosciences,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2018)		 12 Months Ending
(Dec 31 2017)		 12 Months Ending
(Sep 30 2017)		 12 Months Ending
(Jun 30 2017)		 12 Months Ending
(Mar 31 2017)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2018 period, Curative Biosciences,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Curative Biosciences, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2018 period, Curative Biosciences,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Curative Biosciences, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Nonalcoholic Beverages Industry #
Consumer Non Cyclical Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Nonalcoholic Beverages Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BEVS's Revenue Growth Ratio versus Nonalcoholic Beverages Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Mar 31 2018 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Mar 31 2018
Reed s Inc -0.08%$ -0.084 millions
Ocean Bio chem Inc-0.09%$ -0.093 millions
Edgewell Personal Care Company-0.47%$ -0.475 millions
Dean Foods Co-0.76%$ -0.761 millions
Molson Coors Beverage Company-1.57%$ -1.572 millions
Foamix Pharmaceuticals Ltd -2.27%$ -2.265 millions
Tootsie Roll Industries Inc-2.54%$ -2.542 millions
Thanksgiving Coffee Co Inc-2.96%$ -2.962 millions
Treehouse Foods Inc -3.58%$ -3.580 millions
Bunge Global Sa-4.32%$ -4.316 millions
Ingredion Incorporated-4.42%$ -4.424 millions
Chase General Corp-4.96%$ -4.962 millions
Seneca Foods Corporation-5.39%$ -5.392 millions
Revlon Inc -5.75%$ -5.749 millions
Cvr Partners Lp-6.40%$ -6.402 millions
Universal Corporation-6.54%$ -6.543 millions
Cf Industries Holdings inc -7.71%$ -7.715 millions
Lifeway Foods Inc -8.85%$ -8.845 millions
Synergy Chc Corp-10.08%$ -10.080 millions
Crimson Wine Group Ltd -10.91%$ -10.910 millions
Natural Health Trends Corp -12.54%$ -12.538 millions
Coca Cola Co-16.36%$ -16.363 millions
Paradise Inc-16.84%$ -16.840 millions
Solesence Inc -16.84%$ -16.844 millions
Golden Growers Cooperative-17.43%$ -17.430 millions
Fitlife Brands Inc -17.45%$ -17.445 millions
Twinlab Consolidated Holdings Inc -18.40%$ -18.399 millions
Jones Soda Co -19.75%$ -19.745 millions
Andersons Inc -25.38%$ -25.384 millions
Royal Hawaiian Orchards, L.p.-29.24%$ -29.244 millions


About Curative Biosciences, Revenue Growth Rates (BEVS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.